Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel M Verbeek

Showing results (31-40 of 237) with videos related to

Pageof 24
Sort By:
Molecular Neurobiology|April 22, 2015
MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal FluidMareike Müller, Lieke Jäkel, Ilona B Bruinsma, et al.
Medicine, Health Care, and Philosophy|January 26, 2019
Valuing biomarker diagnostics for dementia care: enhancing the reflection of patients, their care-givers and members of the wider publicSimone van der Burg, Floris H B M Schreuder, Catharina J M Klijn, et al.
Clinical Science (London, England : 1979)|October 1, 2017
Animal models of cerebral amyloid angiopathyLieke Jäkel, William E Van Nostrand, James A R Nicoll, et al.
The American Journal of Pathology|July 29, 2005
Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor proteinJianting Miao, Feng Xu, Judianne Davis, et al.
Neurochemistry International|August 12, 2009
Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease)Graham W Kay, Marcel M Verbeek, Julie M Furlong, et al.
JAMA Neurology|September 4, 2013
Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic reviewWilhelmina G Leen, Ron A Wevers, Erik-Jan Kamsteeg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 28, 2024
Metabolite transport across central nervous system barriersGesa Carstens, Marcel M Verbeek, Ursula K Rohlwink, et al.
Molecular Neurobiology|January 19, 2020
Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42Lieke Jäkel, Elisanne A L M Biemans, Catharina J M Klijn, et al.
Ebiomedicine|July 9, 2026
Serum aromatic l-amino acid decarboxylase activity as a biomarker for prodromal and manifest Parkinson's diseaseMilan Beckers, Iris Kersten, Lukas Pavelka, et al.
Neurobiology of Aging|May 9, 2006
CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's diseaseW Farid Abdo, Bastiaan R Bloem, Wieneke J Van Geel, et al.
Pageof 24

Showing results (31-40 of 237) with videos related to

Sort By:
Pageof 24
Molecular Neurobiology|April 22, 2015
MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal FluidMareike Müller, Lieke Jäkel, Ilona B Bruinsma, et al.
Medicine, Health Care, and Philosophy|January 26, 2019
Valuing biomarker diagnostics for dementia care: enhancing the reflection of patients, their care-givers and members of the wider publicSimone van der Burg, Floris H B M Schreuder, Catharina J M Klijn, et al.
Clinical Science (London, England : 1979)|October 1, 2017
Animal models of cerebral amyloid angiopathyLieke Jäkel, William E Van Nostrand, James A R Nicoll, et al.
The American Journal of Pathology|July 29, 2005
Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor proteinJianting Miao, Feng Xu, Judianne Davis, et al.
Neurochemistry International|August 12, 2009
Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease)Graham W Kay, Marcel M Verbeek, Julie M Furlong, et al.
JAMA Neurology|September 4, 2013
Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic reviewWilhelmina G Leen, Ron A Wevers, Erik-Jan Kamsteeg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 28, 2024
Metabolite transport across central nervous system barriersGesa Carstens, Marcel M Verbeek, Ursula K Rohlwink, et al.
Molecular Neurobiology|January 19, 2020
Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42Lieke Jäkel, Elisanne A L M Biemans, Catharina J M Klijn, et al.
Ebiomedicine|July 9, 2026
Serum aromatic l-amino acid decarboxylase activity as a biomarker for prodromal and manifest Parkinson's diseaseMilan Beckers, Iris Kersten, Lukas Pavelka, et al.
Neurobiology of Aging|May 9, 2006
CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's diseaseW Farid Abdo, Bastiaan R Bloem, Wieneke J Van Geel, et al.
Pageof 24